The goal of this clinical trial is to assess the feasibility of an adapted physical activity (APA) program in adult patients (≥18 years) with primary brain tumors, regardless of tumor type, grade, treatment stage, or the presence of motor, sensory, attention, concentration, or memory deficits.
The main question it aims to answer is:
What is the effective adherence rate to an APA program among eligible patients with primary brain tumors?
Additional questions include:
* What is the observance rate (number of sessions completed, intensity achieved, and duration) during the 3-month supervised APA program? * What is the retention rate (proportion of patients completing the program and continuing APA beyond the initial period)? * What is the impact of APA on quality of life, anxiety-depression, and cancer-related symptoms (measured via QLQ-BN20, HADS, and MFI-20 questionnaires at baseline, 3, and 4 months)?
Participants will:
* Undergo a 3-month supervised APA program (with possible continuation beyond this period). * Use connected watches to monitor physical activity (if they accept the general conditions of use). * Complete self-questionnaires (IPAQ, BREQ-2, QPP, QLQ-BN20, HADS, MFI-20) at inclusion, 3 months, and 4 months. * Be followed for a total of 4 months after inclusion.
Men or women ≥ 18 years old,
Receiving medical oncology treatment at the CLCC Eugène Marquis,
Diagnosed with a primary brain tumour, regardless of diagnosis, grade or treatment,
Possible motor, sensory, attention, concentration, or memory deficits,
WHO score ≥ 3
Comprehension disorders that prevent participation in adapted physical activity
Pregnant or breastfeeding women
Patients without the necessary devices to use a smartwatch (smartphone, tablet or computer),
Center Eugene Marquis
Lead sponsor
University of Rennes 2
Collaborator